Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 156

    1.

    The importance of measuring executive function when studying the effects of cognition-enhancing agents.

    Rockwood K.

    Ann Intern Med. 2008 Sep 2;149(5):358-9; author reply 359-60. No abstract available. PMID: 18765709 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The emperor has no clothes: dementia treatment on the eve of the aging era.

    Royall DR.

    J Am Geriatr Soc. 2005 Jan;53(1):163-4. No abstract available. Erratum in: J Am Geriatr Soc. 2005 Mar;53(3):556. PMID: 15667396 [PubMed - indexed for MEDLINE]Related articles

    3.

    [Good evidence for benefits of cholinesterase inhibitors in Parkinson dementia is still missing]

    Larsson A.

    Lakartidningen. 2006 May 10-16;103(19):1537; discussion 1537-8. Swedish. No abstract available. PMID: 16805251 [PubMed - indexed for MEDLINE]Related articles

    4.

    [A reply to Pfizer: Still no reason to change SBU's conclusions on drugs against dementia]

    Edhag O, Norlund A.

    Lakartidningen. 2007 Jan 10-16;104(1-2):55. Swedish. No abstract available. PMID: 17323745 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Antidementia drugs--who has the benefit?]

    Gogol M, Förstl H.

    Internist (Berl). 2008 Jun;49(6):761-2; author reply 762. German. No abstract available. PMID: 18481040 [PubMed - indexed for MEDLINE]Related articles

    6.

    Treating the dementia of Iris with a cholinesterase inhibitor.

    Jacoby R.

    Int J Geriatr Psychiatry. 2003 Aug;18(8):756. No abstract available. PMID: 12891646 [PubMed - indexed for MEDLINE]Related articles

    7.

    SIGN guideline for the management of patients with dementia.

    Connelly PJ, James R.

    Int J Geriatr Psychiatry. 2006 Jan;21(1):14-6. No abstract available. PMID: 16353165 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Drug therapy for psychological symptoms of dementia--comparison between western and oriental medicine]

    Iwasaki K.

    Fukuoka Igaku Zasshi. 2006 Mar;97(3):53-4. Review. Japanese. No abstract available. PMID: 16768175 [PubMed - indexed for MEDLINE]Related articles

    9.

    [SBU-report erroneously quoted in a Pfizer advertisement]

    Norlund A, Levi R, Rosén M.

    Lakartidningen. 2006 Dec 13;103(50-52):4059-60; author reply 4060. Swedish. No abstract available. PMID: 17333544 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cholinesterase inhibitors in dementia: yes, no, or maybe?

    Lemstra AW, Richard E, van Gool WA.

    Age Ageing. 2007 Nov;36(6):625-7. Epub 2007 Sep 19. No abstract available. PMID: 17881419 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.

    Qaseem A, Snow V, Cross JT Jr, Forciea MA, Hopkins R Jr, Shekelle P, Adelman A, Mehr D, Schellhase K, Campos-Outcalt D, Santaguida P, Owens DK; American College of Physicians/American Academy of Family Physicians Panel on Dementia.

    Ann Intern Med. 2008 Mar 4;148(5):370-8.PMID: 18316755 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Psychotherapeutic medications and dementia.

    Hodgson NA, Gitlin LN, Winter L, Dennis M.

    Consult Pharm. 2008 May;23(5):357-8. No abstract available. PMID: 18556821 [PubMed - indexed for MEDLINE]Related articles

    13.

    Role of cholinesterase inhibitors in dementia care: memory clinics and cholinesterase inhibitors have their place.

    Jolley DJ, Benbow SM.

    BMJ. 2006 Sep 16;333(7568):602. No abstract available. PMID: 16974022 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Role of cholinesterase inhibitors in dementia care: NICE's economic analysis has limitations.

    Phillips RJ, Bosanquet N.

    BMJ. 2006 Sep 16;333(7568):603. No abstract available. PMID: 16974027 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Role of cholinesterase inhibitors in dementia care needs rethinking.

    Pelosi AJ, McNulty SV, Jackson GA.

    BMJ. 2006 Sep 2;333(7566):491-3. Review. No abstract available. PMID: 16946340 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Ginkgo and memory.

    Doraiswamy PM, Pomara N.

    JAMA. 2003 Feb 5;289(5):547; author reply 547-8. No abstract available. PMID: 12578474 [PubMed - indexed for MEDLINE]Related articles

    17.

    NICE to see the bigger picture.

    [No authors listed]

    Lancet Neurol. 2006 Feb;5(2):103. No abstract available. PMID: 16426980 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cholinesterase inhibitors for vascular dementia?

    Schneider LS.

    Lancet Neurol. 2003 Nov;2(11):658-9. Review. No abstract available. PMID: 14572732 [PubMed - indexed for MEDLINE]Related articles

    19.

    Summaries for patients. Drug treatment for patients with dementia: American College of Physicians and American Academy of Family Physicians recommendations.

    [No authors listed]

    Ann Intern Med. 2008 Mar 4;148(5):I41. No abstract available. PMID: 18316749 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Dementia, drugs and doing the right thing.

    Kohli HS.

    Natl Med J India. 2007 Jan-Feb;20(1):36-7. No abstract available. PMID: 17557524 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data